Wall Street Zen Upgrades Intuitive Surgical (NASDAQ:ISRG) to Buy

Intuitive Surgical (NASDAQ:ISRG) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, Wall Street Zen reports.

A number of other research analysts have also recently weighed in on the stock. Truist Financial dropped their target price on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. Oppenheimer upgraded shares of Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 price target for the company in a research note on Wednesday, August 12th. JPMorgan Chase & Co. lowered their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a report on Friday, July 17th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, August 14th. Finally, BTIG Research reissued a “buy” rating and set a $469.00 price objective on shares of Intuitive Surgical in a report on Tuesday, September 8th. Twenty-two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $508.68.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $369.15 on Friday. The firm has a market capitalization of $130.41 billion, a P/E ratio of 42.29, a price-to-earnings-growth ratio of 2.79 and a beta of 1.47. The business’s fifty day simple moving average is $376.27 and its 200 day simple moving average is $423.34. Intuitive Surgical has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business’s revenue was up 18.4% compared to the same quarter last year. During the same period last year, the firm posted $1.81 EPS. Analysts predict that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 10,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the sale, the director owned 1,245,679 shares of the company’s stock, valued at $498,271,600. The trade was a 0.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president owned 5,320 shares in the company, valued at approximately $2,016,280. This represents a 6.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 11,281 shares of company stock valued at $4,484,224. 0.60% of the stock is owned by corporate insiders.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the period. Sivia Capital Partners LLC boosted its position in shares of Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the period. Schnieders Capital Management LLC. grew its stake in Intuitive Surgical by 38.0% during the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after acquiring an additional 268 shares in the last quarter. Osterweis Capital Management Inc. bought a new stake in Intuitive Surgical during the 2nd quarter worth approximately $200,000. Finally, Main Street Financial Solutions LLC increased its holdings in Intuitive Surgical by 92.4% during the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after acquiring an additional 1,407 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.